Serious Gaming for Chemotherapy-induced Nausea and Vomiting
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Central Florida
- Study ID
- NCT05838638
- Status
- Recruiting
Conditions
- Chemotherapy-induced Nausea and Vomiting
- Neoplasms
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- eSSET-CINV — BEHAVIORALParticipants in the intervention group will be asked to play the serious game on an iPad at their first chemotherapy treatment visit. The control group will be able to play at time 6.
Study Details
The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.
Key Dates
- Start date
- Jun 9, 2023
- Status verified
- May 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 610 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: InterventionThis intervention is a serious game which allows older adults under treatment for cancer to practice making self-care decisions for an avatar that is being sent home after their first chemotherapy treatment. This serious game is coupled with a discussion with the research assistant about choices related to managing nausea and vomiting at home
- Active Comparator: ControlThe control group will receive standard education related to managing nausea and vomiting and will have the opportunity to participate in the intervention at the end of the study
Primary Outcome Measure
Healthcare resource use [ Time Frame: From baseline through the end of the study at 12 or 24 weeks ]
Central Contacts
- Victoria Loerzel, PhD407-823-0762
- Michael Owings407-440-1309
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Miller School of Medicine Sylvester Comp. Cancer Center | Miami | Florida | 33136 | Deborah Anglade, PhD |
| Orlando Health | Orlando | Florida | 32806 | Aurea Middleton, MSN Aurea Middleton, MSN (SUB_INVESTIGATOR) |
Find similar trials in Miami, FL
Related Studies
- Registry Study for Radiation Therapy OutcomesRecruiting · Proton Collaborative Group · Scottsdale, Arizona
- RSSearch Patient Registry-Long Term Study of Use of SRS/SBRTRecruiting · The Radiosurgery Society · Colorado Springs, Colorado
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsPHASE2/PHASE3 · Recruiting · Celgene · Birmingham, Alabama
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Marengo Therapeutics, Inc. · Loma Linda, California